Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Cash & Current Investments (2016 - 2025)

Pediatrix Medical (MD) has disclosed Cash & Current Investments for 17 consecutive years, with $499.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Current Investments rose 43.39% to $499.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $499.7 million, a 43.39% increase, with the full-year FY2025 number at $499.7 million, up 43.39% from a year prior.
  • Cash & Current Investments was $499.7 million for Q4 2025 at Pediatrix Medical, up from $463.1 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $499.7 million in Q4 2025 to a low of $96.8 million in Q1 2022.
  • A 5-year average of $250.9 million and a median of $198.5 million in 2023 define the central range for Cash & Current Investments.
  • Peak YoY movement for Cash & Current Investments: plummeted 78.84% in 2022, then skyrocketed 161.51% in 2025.
  • Pediatrix Medical's Cash & Current Investments stood at $487.1 million in 2021, then tumbled by 78.84% to $103.1 million in 2022, then soared by 72.46% to $177.7 million in 2023, then soared by 96.07% to $348.5 million in 2024, then soared by 43.39% to $499.7 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Cash & Current Investments are $499.7 million (Q4 2025), $463.1 million (Q3 2025), and $348.3 million (Q2 2025).